Author: GlobeNewswire

WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) — Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused…

SAN DIEGO, Nov. 26, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing…

TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that…

NEW HAVEN, Conn., Nov. 25, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters for vepdegestrant,…

Webcast planned for Monday, November 25th at 8:00 AM ETAUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc.…

– Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been…

CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…

LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James…

DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2024 Annual General Meeting The Board of DXS International plc (“the Company” or…

NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing…